Table Of Content Antibiotic Resistance and Prescribing in European Children... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Associação de Saúde Infantil de Coimbra... 5 University of Tartu... 5 University Medical Centre Ljubljana... 5 Vilnius University Children Hospital... 5 The European Society for Paediatric Infectious Diseases (until 01/07/2013)... 5 Fondazione PENTA for the treatment and care of children with HIV and related diseases - ONLUS... 5 University Medical Center Freiburg... 5 Erasmus Universitair Medisch Centrum Rotterdam... 5 Universiteit Antwerpen... 5 Servicio Madrileno de Salud - (SERMAS)... 5 Università Degli Studi Di Milano... 5 Consorzio per Valutazioni Biologiche e Farmacologiche... 5 Società Servizi Telematici s.r.l.... 5 National and Kapodistrian University of Athens... 5 Outputs... 8 D01 - Formalised Community Project Protocol 'Protocol for Drug Utilization Study' (EN)... 8 D02-01 - Interim Report 'Primary Care Anti-infective agent prescribing for Common Childhood Infections' (EN)... 8 D03-01 - Final Report 'Primary Care Anti-infective agent prescribing for Common Childhood Infections' (EN)... 8 D03-02 - Final Report 'Primary Care Anti-infective agent prescribing for Common Childhood Infections' (EN)... 8 D04-01 - 'Introductory Training Module in Prudent Antibiotic Prescribing' (EN)... 8 D05 - 'Interim Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals' (EN)... 8 D06-01 - Final Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals (EN)... 8 D07-01 - 'EARSS based Paediatric antimicrobial resistance tool' (EN)... 8 D08-01 - Report 'Variation on antimicrobial resistance for key pathogens causing serious infections in children (EN)... 8 D09-01 - Report 'Variation of antibiotic prescribing guidelines' (EN)... 8 D10-01 - Intermediate Technical and Financial reports & Final Technical and Financial reports (EN)... 8 D10-02 - Intermediate Technical and Financial reports & Final Technical and Financial reports (EN)... 8 D10-03 - Intermediate Technical and Financial reports & Final Technical and Financial reports (EN)... 8 Final Technical Report... 8 Flyers (EN)... 8 Internal Assessment (EN)... 8 Leaflets (EN)... 8 Page 1/11
Antibiotic Resistance and Prescribing in European Children JA2015 - GPSD [705038] START DATE: 01/09/2010 END DATE: 01/01/2014 DURATION: 40 month(s) CURRENT STATUS: Finalised PROGRAMME TITLE: Second Programme of Community action in the Field of Health 2008-2013 PROGRAMME PRIORITY: - CALL: Improve Citizen''S Health Security (Hs-2009) TOPIC: IMPROVE CITIZEN'S HEALTH SECURITY (HS-2009) EC CONTRIBUTION: 683048.75 EUR KEYWORDS: Antimicrobial Resistance, Bacteria, Children, Emergent pathogens, Treatment PORTFOLIO: Antimicrobial resistance Page 2/11
SUMMARY General objectives The general objective of the project is to improve the quality of antibiotic prescribing for children in Europe. The specific objectives include determining the variation in antibiotic prescribing for common childhood infections in the community and hospitals across Europe, compared to local guidelines. The project will also systematically compare rates of antimicrobial resistance. There has been a limited focus on education on antimicrobial resistance on pediatricians. The project will aim to kick start a new network of PID specialists working in close collaboration and building on the existing EU funded surveillance projects. ARPEC will use key opinion leaders within ESPID to try to develop the evidence base for the variation in antibiotic resistance and prescribing. This will then directly translate into long term educational programmes focussing on trainee pediatricians and formalise educational training packages in prudent antimicrobial prescribing. Strategic relevance and contribution to the public health programme The World Heath Assembly of 1998 urged member states to develop sustainable systems to monitor volumes and patterns of antimicrobials, detect resistant pathogens and improve educational programmes encouraging prudent antimicrobial use. The project will build on the ESAC and EARSS programmes, working with the ECDC to develop a sustainable surveillance and educational programme for antimicrobial prescribing and antibiotic resistance in children. The core focus of the project is the optimisation of antimicrobial prescribing for children in Europe and this remains a key part of the ECDC work plan. The aim of this first phase of the project is to make the long term routine data collection self-sustainable from participating countries, with the future focus being on the optimal educational methodologies to reduce inappropriate prescribing. Methods and means The project will determine the variation in drug, dose and indications for community and hospital antibiotic prescribing for common childhood infections between EU countries. For community pediatric prescribing variation in both overall and antibiotic class-specific rates will be determined between countries. The programme will produce a novel pediatric defined daily dose (DDD) methodology and conduct an EUwide point prevalence survey to compare antibiotic use in children in hospital. Using established EARSS methodology, information on bacteremia rates and antimicrobial susceptibility patterns for selected common pathogens in Europe will be collected for major children`s hospitals in Partner countries. ARPEC will feed back the project results through regional meetings and use an established web-based methodology for a new ESPID educational training programme Page 3/11
on prudent prescribing. Expected outcomes period The PPS study would provide for the first time detailed indication and age specific hospital prescribing data on antibiotics for medical and surgical treatment and prophylaxis. Key Outcome: Direct comparison data on hospital antibiotic prescribing practice that can be fed directly back to prescribers. The Antimicrobial resistance work package will identify resistance rates for specific pathogens to selected antibiotics in children. 2 key outcomes will be: 1)identify trends in penicillin-resistant pneumococci between countries following introduction of conjugate pneumococcal vaccine across Europe as the date of introduction, the schedule and uptake of this vaccine vary significantly. 2) determination of the spread of multi-resistant gram negative pathogens in community and hospitals in Europe. Community antibiotic prescribing for common childhood infections WP. Key outcome: differences in actual prescribed antibiotics for specific countries compared to their guidelines. This data will provide the basis for future intervention programmes to reduce inappropriate antibiotic prescribing. Page 4/11
COORDINATOR, LEADER CONTACT AND PARTNERS COORDINATOR St George's University of London (St George's University of London) Cranmer Terrace SW17 0RE London United Kingdom Project leader contact Name: Sharland Mike Email: mike.sharland@st.georges.nhs.uk Phone: +44 208 725 3922 PARTNERS Associação de Saúde Infantil de Coimbra Street: Hospital Pediátrico de Coimbra, Av. Bissaya Barreto City: 3000-075 Coimbra Country: Portugal University of Tartu Street: Ülikooli 18 City: 50090 Tartu Country: Estonia University Medical Centre Ljubljana Street: Zaloška cesta 002 City: 1000 Ljubljana Country: Slovenia Page 5/11
Vilnius University Children Hospital Street: Santariskiu 4 City: LT-08406 Vilnius Country: Lithuania The European Society for Paediatric Infectious Diseases (until 01/07/2013) Street: Peters, Schoenberger & Partner GbRzHd Frau Ina BestlerSchackstr. 2 City: D-80539 Muenchen Country: Germany Fondazione PENTA for the treatment and care of children with HIV and related diseases - ONLUS Street: Via Giustiniani 3 City: 35128 Padova Country: Italy University Medical Center Freiburg Street: Hugstetter Str. 55 City: 79106 Freiburg Country: Germany Erasmus Universitair Medisch Centrum Rotterdam Street: 's Gravendijkwal City: 3015CE Rotterdam Country: Netherlands Universiteit Antwerpen Street: Prinsstraat 13 City: 2000 Antwerpen Country: Belgium Page 6/11
Servicio Madrileno de Salud - (SERMAS) Street: Plaza Carlos Tris Bertran 7 City: 28020 Madrid Country: Spain Università Degli Studi Di Milano Street: via Festa del Perdono 7 City: 20122 Milano Country: Italy Consorzio per Valutazioni Biologiche e Farmacologiche Street: Via Palestro 26 City: 27100 Pavia Country: Italy Società Servizi Telematici s.r.l. Street: Via G. Medici 9/A City: 35138 Padova Country: Italy National and Kapodistrian University of Athens Street: Christou Lada 6 City: 105 61 Athens Country: Greece Page 7/11
OUTPUTS D01 - Formalised Community Project Protocol 'Protocol for Drug Utilization Study' (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d01_prot ocol_en_ps.pdf D02-01 - Interim Report 'Primary Care Antiinfective agent prescribing for Common Childhood Infections' (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d02-01_ff r_en_ps1.pdf D03-01 - Final Report 'Primary Care Antiinfective agent prescribing for Common Childhood Infections' (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d03-01_w eb_based_survey_en_is.pdf D03-02 - Final Report 'Primary Care Antiinfective agent prescribing for Common Childhood Infections' (EN) Page 8/11
http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d03-02_p rotocol_en_is.pdf D04-01 - 'Introductory Training Module in Prudent Antibiotic Prescribing' (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d04-01_ff r_en_ps.pdf D05 - 'Interim Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals' (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d05_stud y_protocol_for_pilot_study_en_is.pdf D06-01 - Final Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d06-01_ff r_en_ps.pdf D07-01 - 'EARSS based Paediatric antimicrobial resistance tool' (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d07-01_ff r_en_is.pdf Page 9/11
D08-01 - Report 'Variation on antimicrobial resistance for key pathogens causing serious infections in children (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d08-01_ff r_en_ps.pdf D09-01 - Report 'Variation of antibiotic prescribing guidelines' (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d09-01_ff r_en_ps.pdf D10-01 - Intermediate Technical and Financial reports & Final Technical and Financial reports (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d10-01_o th-05_en_is.pdf D10-02 - Intermediate Technical and Financial reports & Final Technical and Financial reports (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d10-02_o th-06_en_is.pdf Page 10/11
Powered by TCPDF (www.tcpdf.org) D10-03 - Intermediate Technical and Financial reports & Final Technical and Financial reports (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d10-03_ft r_en_is.pdf Final Technical Report http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_d10-03_ft r_en_is1.pdf Flyers (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_oth-02_la y-01_en_ps.pdf Internal Assessment (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_po_asses ssment_note_en_is.pdf Leaflets (EN) http://azorina.cc.cec.eu.int:8082/publications/20091101/20091101_oth-01_lft -01_en_ps.pdf Page 11/11